Cell Metabolism. Vol. 19, no. 6. (June 3, 2014): 1034–1041. doi: 10.1016/j.cmet.2014.04.002.
8. Massudi H, Grant R, Braidy N, Guest J, Farnsworth B, Guillemin GJ. “AgeAssociated Changes in Oxidative Stress and NAD+ Metabolism in Human Tissue.” PLoS One. Vol. 7, no. 7. (2012): e42357.
9. Braidy N, Guillemin GJ, Mansour H, Chan-Ling T, Poljak A, Grant R. “Age Related Changes in NAD+ Metabolism, Oxidative Stress, and Sirt1 Activity in Wistar Rats.” PLoS One. Vol. 6, no. 4. (April 26, 2011): e19194.
10. Makvandi M, Sellmyer MA, Mach RH. “Inflammation and DNA Damage: Probing Pathways to Cancer and Neurodegeneration.” Drug Discovery Today: Technologies. Vol. 25. (November 2017): 37–43. doi: 10.1016/j.ddtec.2017.11.001.
11. Berger, F. “The New Life of a Centenarian: Signalling Functions of NAD(P).” Trends in Biochemical Sciences. Vol. 29, no. 3. (2004): 111–118. doi: 10.1016/j.tibs.2004.01.007.
12. Warburg O, Pyridine CW. “Pyridine, the Hydrogen Transfusing Component of Fermentative Enzymes.” Helvetica Chimica Acta. Vol. 19. (1936): 79–88.
13. Sinclair DA, Guarente L. “Unlocking the Secrets of Longevity Genes.” Scientific American. Vol. 294, no. 3. (March 2006): 48–51, 54–57.
14. Romani M. “Niacin: An Old Lipid Drug in a New NAD+ Dress.” Journal of Lipid Research. Vol. 60, no. 4. (April 2019): 741–746. doi: 10.1194/jlr.S092007.
15. Braidy N, Berg J, Clement J, Khorshidi F, Poliak A, Javasena T, Grant R, Sachdev P. “Role of NAD+ and Related Precursors as Therapeutic Targets for Age-Related Degenerative Diseases: Rationale, Biochemistry, Pharmacokinetics, and Outcomes.” Antioxidants & Redox Signal. Vol. 30, no. 2. (January 10, 2019): 251–294. doi: 10.1089/ars.2017.7269.
16. Ansari HR, Raghava GP. “Identification of NAD Interacting Residues in Proteins.” BMC Bioinformatics. Vol. 11. (March 30, 2010): 160.
17. Placzek S, Schomburg I, Chang A, Jeske L, Ulbrich M, Tillack J, Schomburg D. “BRENDA in 2017: New Perspectives and New Tools in BRENDA.” Nucleic Acids Research. Vol. 45. (January 4, 2017): D380–D388.
18. Conze D, Brenner C, Kruger CL. “Safety and Metabolism of Long-Term Administration of NIAGEN (Nicotinamide Riboside Chloride) in a Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Healthy Overweight Adults.” Scientific Reports. Vol. 9, no. 1. (July 5, 2019): 9772. doi: 10.1038/s41598-019-46120-z.
19. Canto C, Menzies KJ, and Auwerx J. “NAD(+) Metabolism and the Control of Energy Homeostasis: A Balancing Act Between Mitochondria and the Nucleus.” Cellular Metabolism. Vol. 22. (2015): 31–53.
20. Won SJ, Choi BY, Yoo BH, Sohn M, Ying W, Swanson R, Suh SW. “Prevention of Traumatic Brain Injury Induced Neuron Death by Intranasal Delivery of NAD+.” Journal of Neurotrauma. Vol. 29, no. 7. (May 1, 2012): 1401–1409.
21. Zhang M, Ying W. “NAD Deficiency Is a Common Central Pathological Factor of a Number of Diseases and Aging: Mechanisms and Therapeutic Implications.” Antioxidants & Redox Signaling. (February 7, 2018.)
22. Hosseini L, Vafaee MS, Mahmoudi J, Badalzadeh R. “Nicotinamide Adenine Dinucleotide Emerges as a Therapeutic Target in Aging and Ischemic Conditions.” Biogerontology. (March 5, 2019). doi: 10.1007/s10522-019-09805.
23. Csiszar A, Tarantini S, Yabluchanskiy A, Balasubramanian P, Kiss T, Farkas E, Baur JA, Ungvari ZI. “Role of Endothelial NAD+ Deficiency in Age-Related Vascular Dysfunction.” American Journal of Physiology-Heart and Circulatory Physiology. (2019). doi: 10.1152/ajpheart.00039.2019.
24. Poulos LH, Poulos TL. “Structure-Function Studies on Nitric Oxide Synthases.” Journal of Inorganic Biochemistry. Vol. 99, no. 1. (January 2005): 293–305.
25. Bradshaw P. “Cytoplasmic and Mitochondrial NADPH-Coupled Redox Systems in the Regulation of Aging.” Nutrients. Vol. 11, no. 3. (February 27, 2019): 504. doi: 10.3390/nu11030504.
26. Placzek S, Schomburg I, Chang A, Jeske L, Ulbrich M, Tillack J, Schomburg D. “BRENDA in 2017: New Perspectives and New Tools in BRENDA.” Nucleic Acids Research. Vol. 45. (January 4, 2017): D380–D388.
27. Curtis W, Kemper ML, Miller AL, Pawlosky R, King MT, Veech RL. “Mitigation of Damage from Reactive Oxygen Species and Ionizing Radiation by Ketone Body Esters.” In Ketogenic Diet and Metabolic Therapies: Expanded Roles in Health and Disease. (Masino SA, ed.). Oxford University Press, Oxford. 2017. Pages 254–270.
28. Harman D. “Free Radical Theory of Aging: An Update: Increasing the Functional Life Span.” Annals of the New York Academy of Sciences. Vol. 1067. (May 2006): 10–21.
29. LaBaron TW, Laher I, Kura B, Slezak J. “Hydrogen Gas: From Clinical Medicine to an Emerging Ergogenic Molecule for Sports Athletes.” Canadian Journal of Physiology and Pharmacology. (April 10, 2019.) doi: 10.1139/cjpp-2019-0067.
30. Selman C, McLaren JS, Meyer C, Duncan JS, Redman P, Collins AR, Duthie GG, Speakman JR. “Life-Long Vitamin C Supplementation in Combination with Cold Exposure Does Not Affect Oxidative Damage or Lifespan in Mice, but Decreases Expression of Antioxidant Protection Genes.” Mechanisms of Ageing and Development. Vol. 127, no. 12. (December 2006): 897–904.
31. Ernst IM, Pallauf K, Bendall JK, Paulsen L, Nikolai S, Huebbe P, Roeder T, Rimbach G. “Vitamin E Supplementation and Lifespan in Model Organisms.” Ageing Research Reviews. Vol. 12, no. 1. (January 2013): 365–375. doi: 10.1016/j.arr.2012.10.002.
32. Bradshaw P. “Cytoplasmic and Mitochondrial NADPH-Coupled Redox Systems in the Regulation of Aging.” Nutrients. Vol. 11, no. 3. (February 27, 2019): 504. doi: 10.3390/nu11030504.
33. Zhu XH, Lu M, Lee BY, Ugurbil K, Chen W. “In Vivo NAD Assay Reveals the Intracellular NAD Contents and Redox State in Healthy Human Brain and Their Age Dependences.” Proceedings of the National Academy of Sciences of the United States of America. Vol. 112, no. 9. (March 3, 2015): 2876–2881.
34. Pollak N, Dolle C, Ziegler M. “The Power to Reduce: Pyridine Nucleotides—Small Molecules with a Multitude of Functions.” Biochemistry Journal. Vol. 402. (March 1, 2007): 205–218. doi: 10.1042/BJ20061638.
35. Panday A, Sahoo MK, Osorio D, Batra S. “NADPH Oxidases: An Overview from Structure to Innate Immunity-Associated Pathologies.” Cellular & Molecular Immunology. Vol. 12, no. 1. (January 12, 2015): 5–23. doi: 10.1038/cmi.2014.89.
36. Brandes RP, Kreuzer J. “Vascular NADPH Oxidases: Molecular Mechanisms of Activation.” Cardiovascular Research. Vol. 65, no. 1. (January 1, 2005): 16–27.
37. Bradshaw P. “Cytoplasmic and Mitochondrial NADPH-Coupled Redox Systems in the Regulation of Aging.” Nutrients. Vol. 11, no. 3. (February 27, 2019): 504. doi: 10.3390/nu11030504.
38. Pacher P, Beckman JS, Liaudet L. “Nitric Oxide and Peroxynitrite in Health and Disease.” Physiological Reviews. Vol. 87, no. 1. (January 2007): 315–424.
39. Slezák J, Kura B, Frimmel K, Zálešák M, Ravingerová T, Viczenczová C, Okruhlicová L’, Tribulová N. “Preventive and Therapeutic Application of Molecular Hydrogen in Situations with Excessive Production of Free Radicals.” Physiological Research. Vol. 65, no. 1. (September 19, 2016): S11–S28.
40. Ohta S. “Molecular Hydrogen as a Novel Antioxidant: Overview of the Advantages of Hydrogen for Medical Applications.” Methods in Enzymology. Vol. 555. (2015): 289–317. doi: 10.1016/bs.mie.2014.11.038.
41. Zhai X, Chen X, Ohta S, and Sun X. “Review and Prospect of the Biomedical Effects of Hydrogen.” Medical Gas Research. Vol. 4, no 1. (2014): 19. doi: 10.1186/s13618-014-0019-6.
42. Gao Q, Song H, Wang XT, Liang Y, Xi YJ, Gao Y, Guo QJ, LeBaron T, Luo YX, Li SC, Yin X, Shi HS, Ma YX. “Molecular Hydrogen Increases Resilience to Stress in Mice.” Scientific Reports. Vol. 7, no. 1. (2017): 9625. doi: 10.1038/s41598-017-10362-6.
43. Sato Y, Kajiyama S, Amano A, Kondo Y, Sasaki T, Handa S, Takahashi R, Fukui M, Hasegawa G, Nakamura N, Fujinawa H, Mori T, Ohta M, Obayashi H. Maruyama N, Ishigami A. “Hydrogen-Rich Pure Water Prevents Superoxide Formation in Brain Slices of Vitamin C-Depleted SMP30/GNL Knockout Mice.” Biochemical and Biophysical Research and Communications. Vol. 375, no. 3. (October 24, 2008): 346–350. doi: 10.1016/j.bbrc.2008.08.020.
44. LeBaron TW, Laher I, Kura B, Slezak J. “Hydrogen Gas: From Clinical Medicine to an Emerging Ergogenic Molecule for Sports Athletes.” Canadian Journal of Physiology and Pharmacology. Vol. 97, no. 9. (September 2019): 797–807. doi: 10.1139/cjpp-2019-0067.
45. Kang KM, Kang YN, Choi IB, Gu Y, Kawamura T, Toyoda Y, Nakao A. “Effects of Drinking Hydrogen-Rich Water on the Quality of Life of Patients Treated with Radiotherapy for Liver Tumors.” Medical Gas Research. 2011 Jun 7; 1 (1): 11. doi: 10.1186/2045-9912-1-11.
46. Yang Q, Ji G, Pan R, Zhao Y, Yan P. “Protective Effect of Hydrogen-Rich Water on Liver Function of Colorectal Cancer Patients Treated with mFOLFOX6 Chemotherapy.” Molecular and Clinical Oncology. Vol. 7, no. 5. (November 2017): 891–896. doi: 10.3892/mco.2017.1409.
47. Batra V, Kislay B. “Mitigation of Gamma-Radiation Induced Abasic Sites in Genomic DNA by Dietary Nicotinamide Supplementation: Metabolic Up-Regulation of NAD+ Biosynthesis.” Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis. Vol. 749, no. 1–2. (2013): 28–38.
Braidy N, Guillemin GJ, Mansour H, Chan-Ling T, Poljak A, Grant R. “Age Related Changes in NAD+ Metabolism Oxidative Stress and Sirt1 Activity in Wistar Rats.” PLoS One. Vol. 6, no. 4. (April 26, 2011): e19194.
48. Sheng C, Chen H, Wang B, Liu T, Hong Y, Shao J, He X, Ma Y, Nie H, Liu N, Xia W, Ying W. “NAD+ Administration Significantly Attenuates Synchrotron Radiation X-Ray-Induced DNA Damage and Structural Alterations of Rodent Testes.”